PERIPHAGEN

periphagen-logo

PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products for neurologic disorders with significant unmet medical need. The intuitive way to treat conditions that directly affect neurons is to target treatment to the neurons themselves. PeriphaGen's first indications of interest are neuropathic pain, neuropathy, and neuronal regeneration. The PeriphaGen NEuronal Therapeutics (NET) platform based drug candidates hav... e the ability to express therapeutic proteins directly and specifically in neurons for four to eight weeks after a simple intradermal application. NET products express natural gene products locally that block pain signaling, protect against neuronal damage, or promote neuronal regeneration without systemic side effects.

#SimilarOrganizations #People #Website #More

PERIPHAGEN

Social Links:

Industry:
Biotechnology Genetics Medical Device Pharmaceutical

Founded:
2012-01-01

Address:
Pittsburgh, Pennsylvania, United States

Country:
United States

Website Url:
http://www.periphagen.com

Total Employee:
1+

Status:
Active

Contact:
(412)488-0348

Email Addresses:
[email protected]

Total Funding:
6.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content Wix


Similar Organizations

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

not_available_image

Dnaprint Genomics

DNAPrint Genomics is a genetics company with a wide range of products related to genetic profiling, forensic & consumer genomics products.

newbridge-pharmaceuticals-logo

NewBridge Pharmaceuticals

Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.

sebela-pharmaceuticals-logo

Sebela Pharmaceuticals

Sebela is committed to improving patientsโ€™ lives by developing, marketing and selling differentiated branded prescription pharmaceuticals.


Current Advisors List

peter-lanciano_image

Peter Lanciano Chairman of the Board, Chairman of the Audit and Finance Committee @ PeriphaGen
Board_member
2014-02-01

Current Employees Featured

not_available_image

James Wechuck
James Wechuck Chief Scientific Officer, Founder @ PeriphaGen
Chief Scientific Officer, Founder

not_available_image

David Krisky
David Krisky Chief Medical Officer, Founder @ PeriphaGen
Chief Medical Officer, Founder

not_available_image

Darren Wolfe
Darren Wolfe Chief Executive Officer, Founder @ PeriphaGen
Chief Executive Officer, Founder

Founder


not_available_image

Darren Wolfe

not_available_image

David Krisky

not_available_image

James Wechuck

Official Site Inspections

http://www.periphagen.com

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "PeriphaGen"

Periphagen

Periphagen is a biopharmaceutical company focused on the development of herpes simplex virus type I (HSV-1) as a gene therapy vector. Our primary focus is the use of HSV-1 vectors for โ€ฆSee details»

PeriphaGen - Crunchbase Company Profile & Funding

PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products for neurologic disorders with significant unmet โ€ฆSee details»

OUR TEAM - periphagen

Prior to founding PeriphaGen Dr. Krisky was the Senior Director of Medical Science and Clinical Safety for Diamyd Incorporated and was responsible for the product development and clinical โ€ฆSee details»

PeriphaGen Inc - LinkedIn

PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological disorders thereby ...See details»

PeriphaGen 2025 Company Profile: Valuation, Investors โ€ฆ

PeriphaGen General Information Description. Operator of a biopharmaceutical company headquartered in Pittsburgh, Pennsylvania. The company develops โ€ฆSee details»

PeriphaGen - The Org

PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological disorders โ€ฆSee details»

Periphagen Company Profile - Craft

Periphagen is a biopharmaceutical company focused on peripheral nerve gene therapy for disorders such as neuropathy and chronic pain. It provides a Neuronal Therapeutics (NET) โ€ฆSee details»

PeriphaGen Inc Overview | SignalHire Company Profile

PeriphaGen Inc is a private company that has been in the industry for 11 years. The company currently specializes in the Pharmaceuticals area. ... Organization Website: periphagen.com : โ€ฆSee details»

PeriphaGen Holdings - VentureRadar

Periphagen is a biopharmaceutical company focused on the development of herpes simplex virus type I (HSV-1) as a gene therapy vector. Our primary focus is the use of HSV-1 vectors for โ€ฆSee details»

PeriphaGen - Contacts, Employees, Board Members, Advisors

PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products. Search Crunchbase. Start Free Trial . Chrome โ€ฆSee details»

CONTACT US - periphagen

PeriphaGen, Inc. 2403 Sidney Street. Suite 255 Pittsburgh, PA 15203 . Success! Message received. Send. PeriphaGen is interested in speaking with potential corporate (pharma) โ€ฆSee details»

PeriphaGen (Herpes Drug Development Platform and โ€ฆ

PeriphaGen (Herpes Drug Development Platform and Manufacturing Expertise) was acquired by Candel Therapeutics. Data Transparency. Meet our data hygiene team. Discover how our โ€ฆSee details»

PeriphaGen - Funding, Financials, Valuation & Investors

PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products. ... Experience the new Crunchbase, powered by โ€ฆSee details»

Periphagen Holdings, Inc. - Drug pipelines, Patents, Clinical trials ...

Explore Periphagen Holdings, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Technology Platform:Gene ...See details»

PeriphaGen - Company profile | ensun

PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological โ€ฆSee details»

Periphagen - Overview, News & Similar companies | ZoomInfo.com

Oct 22, 2018 Krystal Biotech Announces Settlement with PeriphaGen, Inc. PITTSBURGH, March 15, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc., (โ€œKrystalโ€) (NASDAQ: KRYS), โ€ฆSee details»

Periphagen Inc Company Information - Funding, Investors, and More

Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»

OUR TECHNOLOGY - periphagen

PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological โ€ฆSee details»

Transfer of youth-serving organization The Link to Brokenhead โ€ฆ

19 hours ago The operation of The Link is being shifted from a not-for-profit organization that relied heavily on government funding to being owned and led by Brokenhead Ojibway Nation. โ€ฆSee details»

OUR PIPELINE - periphagen

PeriphaGenโ€™s NET vector technology allows for targeted delivery to specific sensory nerves via a simple intradermal skin injection, thus our lead products have focused on treating peripheral โ€ฆSee details»

linkstock.net © 2022. All rights reserved